Protein expression profiles indicative for drug resistance of non-small cell lung cancer

被引:0
|
作者
M Volm
R Koomägi
J Mattern
T Efferth
机构
[1] German Cancer Research Centre,
[2] Virtual Campus Rhineland-Palatinate,undefined
来源
British Journal of Cancer | 2002年 / 87卷
关键词
non-small cell lung carcinomas; resistance factors; hierarchical cluster analysis;
D O I
暂无
中图分类号
学科分类号
摘要
Data obtained from multiple sources indicate that no single mechanism can explain the resistance to chemotherapy exhibited by non-small cell lung carcinomas. The multi-factorial nature of drug resistance implies that the analysis of comprising expression profiles may predict drug resistance with higher accuracy than single gene or protein expression studies. Forty cellular parameters (drug resistance proteins, proliferative, apoptotic, and angiogenic factors, products of proto-oncogenes, and suppressor genes) were evaluated mainly by immunohistochemistry in specimens of primary non-small cell lung carcinoma of 94 patients and compared with the response of the tumours to doxorubicin in vitro. The protein expression profile of non-small cell lung carcinoma was determined by hierarchical cluster analysis and clustered image mapping. The cluster analysis revealed three different resistance profiles. The frequency of each profile was different (77, 14 and 9%, respectively). In the most frequent drug resistance profile, the resistance proteins P-glycoprotein/MDR1 (MDR1, ABCB1), thymidylate-synthetase, glutathione-S-transferase-π, metallothionein, O6-methylguanine-DNA-methyltransferase and major vault protein/lung resistance-related protein were up-regulated. Microvessel density, the angiogenic factor vascular endothelial growth factor and its receptor FLT1, and ECGF1 as well were down-regulated. In addition, the proliferative factors proliferating cell nuclear antigen and cyclin A were reduced compared to the sensitive non-small cell lung carcinoma. In this resistance profile, FOS was up-regulated and NM23 down-regulated. In the second profile, only three resistance proteins were increased (glutathione-S-transferase-π, O6-methylguanine-DNA-methyltransferase, major vault protein/lung resistance-related protein). The angiogenic factors were reduced. In the third profile, only five of the resistance factors were increased (MDR1, thymidylate-synthetase, glutathione-S-transferase-π, O6-methylguanine-DNA-methyltransferase, major vault protein/lung resistance-related protein).
引用
收藏
页码:251 / 257
页数:6
相关论文
共 50 条
  • [31] Drug Resistance to EGFR Tyrosine Kinase Inhibitors for Non-small Cell Lung Cancer
    Shien, Kazuhiko
    Yamamoto, Hiromasa
    Soh, Junichi
    Miyoshi, Shinichiro
    Toyooka, Shinichi
    ACTA MEDICA OKAYAMA, 2014, 68 (04) : 191 - 200
  • [32] Non-Small Cell Lung Cancer Targeted Therapy: Drugs and Mechanisms of Drug Resistance
    Wu, Jiajia
    Lin, Zhenghong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [33] Mechanisms of drug resistance to immune checkpoint inhibitors in non-small cell lung cancer
    Zhou, Kexun
    Li, Shuo
    Zhao, Yi
    Cheng, Ke
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [35] Methylmalonic acid is elevated in non-small cell lung cancer and promotes drug resistance
    Parang, Bobak
    Li, Zhongchi
    Low, Vivien
    Endress, Jennifer
    Malbari, Murtaza
    Saxena, Ashish
    Altorki, Nasser
    Blenis, John
    CANCER RESEARCH, 2022, 82 (12)
  • [36] The emerging role of circular RNAs in drug resistance of non-small cell lung cancer
    Yan, Tinghao
    Tian, Xinchen
    Liu, Fen
    Liu, Qingbin
    Sheng, Qing
    Wu, Jianlin
    Jiang, Shulong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [37] Analysis of Long Non-Coding RNA Expression Profiles in Non-Small Cell Lung Cancer
    Wang, Li
    Chen, Zhenhong
    An, Li
    Wang, Yajuan
    Zhang, Zhijian
    Guo, Yinghua
    Liu, Changting
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 38 (06) : 2389 - 2400
  • [38] Transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer
    Bar, Jair
    Ofek, Efrat
    Barshack, Iris
    Gottfried, Teodor
    Zadok, Oranit
    Kamer, Iris
    Urban, Damien
    Perelman, Marina
    Onn, Amir
    LUNG CANCER, 2019, 138 : 109 - 115
  • [39] Enhanced expression of stem cell markers and drug resistance in sphere-forming non-small cell lung cancer cells
    Sun, Feng-Feng
    Hu, Yong-He
    Xiong, Lv-Ping
    Tu, Xiao-Yun
    Zhao, Ji-Hua
    Chen, Sheng-Song
    Song, Juan
    Ye, Xiao-Qun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (06): : 6287 - 6300
  • [40] Non-small cell lung cancer molecular profiles are associated with lung development
    Borczuk, AC
    Assaad, AM
    Wang, LQQ
    Walter, KL
    Powell, CA
    CHEST, 2004, 125 (05) : 115S - 116S